NCT00064376View on ClinicalTrials.gov

Paricalcitol in Treating Patients With Myelodysplastic Syndrome

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2003

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
LeukemiaMyelodysplastic Syndromes
Interventions
DRUG

paricalcitol

Trial Locations (1)

90048

Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Cedars-Sinai Medical Center

OTHER